Second Sight Medical Products Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.46 |
Market Cap |
$97.72 M |
Shares Outstanding |
124.2 M |
Public Float |
82.66 M |
Address |
12744 San Fernando Road Sylmar California 91342 United States |
Employees | - |
Website | http://www.secondsight.com |
Updated | 07/08/2019 |
Second Sight Medical Products, Inc. develops, manufactures and markets prosthetic devices. Its product the Argus II System, treats outer retinal degenerations and employs electrical stimulation to bypass degenerated photoreceptor cells and to stimulate remaining viable retinal cells thereby inducing visual perception in blind individuals. The firm's system works by converting video images captured by a miniature camera housed in a patient's glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes that are implanted on the surface of the retina. |